louisiana glp-1 stomach paralysis lawsuit semaglutide legal team in semaglutide gi obstruction law firm in louisiana kentucky semaglutide gastrointestinal obstruction lawyer Kentucky Ozempic Lawyers semaglutide stomach paralysis attorney in louisiana glp-1 gastroparesis class action

J Pediatrics

W.HartoppN.WelshN

Other medications the patient may be takingincluding certain antibiotics, anticonvulsants, or immunomodulatory agentsshould be reviewed

Clinical Evidence Human Trials: A randomized, placebo-controlled study in obese adults demonstrated that AOD-9604 significantly reduced abdominal and total body fat over several weeks of treatment, without serious side effects Animal Studies: Preclinical studies in mice and rats showed that AOD-9604: Stimulated lipolysis Inhibited lipogenesis (formation of new fat) Prevented weight gain despite high-fat diets This dual actionenhancing fat breakdown and inhibiting fat formationpositions AOD-9604 as a potent tool for combating obesity